Denosumab mid-term densitometric gain in postmenopausal osteoporosis women in clinical practice: comment on «Variability of denosumab densitometric response in postmenopausal osteoporosis.

Patrocinadores de la web
Lilly
Angelini
Laboratorios Rubió
Grupo Italfármaco
UCB-Pharma
Theramex
Stada
Gedeon Richter